Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
240 participants
INTERVENTIONAL
2022-02-01
2025-03-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Neural Correlates of Stress Hormones
NCT02523664
Narrative Exposure Therapy in Women With Borderline Personality Disorder and Posttraumatic Stress Disorder
NCT02517723
Outcome of Crisis Intervention for Subjects With Borderline Personality Disorder or Post-Traumatic Stress Disorder
NCT00269139
Treating PTSD in Patients With Borderline Personality Disorder
NCT01081314
Cognitive Processing Therapy (CPT) for Posttraumatic Stress Disorder and Borderline Personality Disorder (PTSD-BPD)
NCT04230668
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
FACTORIAL
OTHER
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Fludrocortisone & TSST - BPD patients
intake of 0.4mg fludrocortisone (orally) before stress
Fludrocortisone
pill of fludrocortisone
Trier Social Stress Test (TSST)
psychosocial stress induction
Fludrocortisone & TSST - Healthy controls
intake of 0.4mg fludrocortisone (orally) before stress
Fludrocortisone
pill of fludrocortisone
Trier Social Stress Test (TSST)
psychosocial stress induction
Placebo pills & TSST - BPD patients
intake of placebo pill before stress
Placebo
placebo pill
Trier Social Stress Test (TSST)
psychosocial stress induction
Placebo pills & TSST - Healthy controls
intake of placebo pill before stress
Placebo
placebo pill
Trier Social Stress Test (TSST)
psychosocial stress induction
Fludrocortisone & Placebo-TSST- BPD patients
intake of 0.4mg fludrocortisone (orally) before "no stress"
Fludrocortisone
pill of fludrocortisone
Placebo Trier Social Stress Test (P-TSST)
control condition
Fludrocortisone & Placebo-TSST - Healthy controls
intake of 0.4mg fludrocortisone (orally) before "no stress"
Fludrocortisone
pill of fludrocortisone
Placebo Trier Social Stress Test (P-TSST)
control condition
Placebo pills & Placebo-TSST - BPD patients
intake of placebo pill before "no stress"
Placebo Trier Social Stress Test (P-TSST)
control condition
Placebo pills & Placebo-TSST - Healthy controls
intake of placebo pill before "no stress"
Placebo
placebo pill
Placebo Trier Social Stress Test (P-TSST)
control condition
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Fludrocortisone
pill of fludrocortisone
Placebo
placebo pill
Trier Social Stress Test (TSST)
psychosocial stress induction
Placebo Trier Social Stress Test (P-TSST)
control condition
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* female
* BMI between 17.5-30
* female
* BMI between 17.5-30
* no clinical diagnosis of any mental disorder
Exclusion Criteria
* acute or lifetime psychotic symptoms
* acute substance abuse
* physical illness
18 Years
60 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Charite University, Berlin, Germany
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Katja Wingenfeld
"Fight-or-flight" versus "tend-and-befriend" response to behavioral and pharmacological interventions in patients with borderline personality disorder
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Charite University
Berlin, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
WI 3396/12-1.2
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.